(Q37705702)

22 August 2017

1 reference

title

Toll-like receptors and genital tract infection (English)

1 reference

22 August 2017

0 references

C Sonnex

1

1 reference

22 August 2017

1 March 2010

1 reference

International Journal of STD & AIDS

22 August 2017

1 reference

22 August 2017

21

1 reference

22 August 2017

3

1 reference

22 August 2017

153-157

1 reference

Innate immune recognition

22 August 2017

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

NK cells in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Dendritic cells and macrophages in the genitourinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Surfactant protein A, an innate immune factor, is expressed in the vaginal mucosa and is present in vaginal lavage fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Toll-like receptors and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

TLR-mediated innate immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Biology of Toll receptors: lessons from insects and mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Cooperation of Toll-like receptor signals in innate immune defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Localization of TLR2 and MyD88 to Chlamydia trachomatis inclusions. Evidence for signaling by intracellular TLR2 during infection with an obligate intracellular pathogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Endotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

The Lip lipoprotein from Neisseria gonorrhoeae stimulates cytokine release and NF-kappaB activation in epithelial cells in a Toll-like receptor 2-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

An altered immunity hypothesis for the development of symptomatic bacterial vaginosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Induction of tumor necrosis factor- alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Atopobium vaginae triggers an innate immune response in an in vitro model of bacterial vaginosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Gene polymorphisms of Toll-like and related recognition receptors in relation to the vaginal carriage of Gardnerella vaginalis and Atopobium vaginae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Mycoplasma genitalium-encoded MG309 activates NF-kappaB via Toll-like receptors 2 and 6 to elicit proinflammatory cytokine secretion from human genital epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

A triacylated lipoprotein from Mycoplasma genitalium activates NF-kappaB through Toll-like receptor 1 (TLR1) and TLR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Ureaplasma parvum lipoproteins, including MB antigen, activate NF-{kappa}B through TLR1, TLR2 and TLR6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Trichomonas vaginalis infection activates cells through toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Dependence on p38 MAPK signalling in the up-regulation of TLR2, TLR4 and TLR9 gene expression in Trichomonas vaginalis-treated HeLa cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Candida albicans phospholipomannan triggers inflammatory responses of human keratinocytes through Toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Toll-like receptors and innate antifungal responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Dendritic cells phagocytose and are activated by Treponema pallidum

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Increased toll-like receptor 9 expression in cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

The role of toll-like receptor ligands/agonists in protection against genital HSV-2 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

Effect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

The function and biological role of toll-like receptors in infectious diseases: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

21 January 2018

TLRs and innate immunity

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009525

21 January 2018

Identifiers

DOI

10.1258/IJSA.2009.009525

1 reference

22 August 2017

1 reference

PubMed ID

20215617